Variant report
Variant | nsv1013180 |
---|---|
Chromosome Location | chr4:93812587-93875433 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:93846312..93847841-chr4:93851226..93853929,2 | K562 | blood: | |
2 | chr4:93757984..93759775-chr4:93817140..93819795,2 | MCF-7 | breast: | |
3 | chr4:93825096..93827296-chr4:93828128..93830318,2 | K562 | blood: | |
4 | chr4:93846312..93847841-chr4:93851226..93853929,2 | K562 | blood: | |
5 | chr4:93827426..93829042-chr4:93829198..93830745,2 | K562 | blood: | |
6 | chr4:93825096..93827296-chr4:93828128..93830318,2 | K562 | blood: | |
7 | chr4:93827426..93829042-chr4:93829198..93830745,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530160781 | chr4:93818044-93818045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543474451 | chr4:93818050-93818051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373363532 | chr4:93818051-93818052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528531684 | chr4:93818054-93818055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111923802 | chr4:93818079-93818080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557863672 | chr4:93818093-93818094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551724744 | chr4:93818115-93818116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs565173259 | chr4:93818133-93818134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527521871 | chr4:93818144-93818145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547575547 | chr4:93818145-93818146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62311171 | chr4:93818147-93818148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567254487 | chr4:93818185-93818186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536320335 | chr4:93818198-93818199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561787997 | chr4:93818370-93818371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11407081 | chr4:93818390-93818391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs397726908 | chr4:93818394-93818395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs202053459 | chr4:93818395-93818396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549530642 | chr4:93818403-93818404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs569667850 | chr4:93818422-93818423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181490945 | chr4:93818481-93818482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572398041 | chr4:93818492-93818493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534890271 | chr4:93818520-93818521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555115643 | chr4:93818549-93818550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574851527 | chr4:93818562-93818563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564591313 | chr4:93818581-93818582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563606967 | chr4:93818582-93818583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183852304 | chr4:93821809-93821810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187780776 | chr4:93821817-93821818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375891988 | chr4:93821845-93821846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192445895 | chr4:93821846-93821847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185056171 | chr4:93821855-93821856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373268812 | chr4:93821875-93821876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34089162 | chr4:93821985-93821986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144047878 | chr4:93822010-93822011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544220554 | chr4:93822024-93822025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs6818303 | chr4:93822050-93822051 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs368627782 | chr4:93822087-93822088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375755928 | chr4:93822088-93822089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs70942936 | chr4:93822100-93822101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201848305 | chr4:93822101-93822102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189041284 | chr4:93822182-93822183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566991639 | chr4:93822199-93822200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547238649 | chr4:93822213-93822214 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560554790 | chr4:93822226-93822227 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529466788 | chr4:93822244-93822245 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150224478 | chr4:93822282-93822283 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569322751 | chr4:93822303-93822304 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537861151 | chr4:93822313-93822314 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551313927 | chr4:93822324-93822325 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369752457 | chr4:93822347-93822348 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:93818000-93818600 | Enhancers | Liver | Liver |
2 | chr4:93821800-93822200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr4:93822200-93823200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr4:93823200-93823800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:93827400-93827800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr4:93827800-93829000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr4:93843200-93843600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr4:93843600-93845800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr4:93845600-93846400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr4:93845600-93846600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr4:93845600-93846600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr4:93845600-93846600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr4:93845600-93846800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr4:93845800-93846200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr4:93845800-93846200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
16 | chr4:93845800-93846200 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr4:93845800-93846400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
18 | chr4:93845800-93846400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr4:93852000-93852400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
20 | chr4:93864200-93866800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
21 | chr4:93864400-93874200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
22 | chr4:93865400-93865800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
23 | chr4:93865800-93895400 | Weak transcription | H1 Cell Line | embryonic stem cell |
24 | chr4:93871200-93883400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
25 | chr4:93871400-93883200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |